Mode
Text Size
Log in / Sign up

Case report describes neurologic complications in two US patients with monkeypoxTwo U.S. patients developed neurological complications during monkeypox infections

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note: Case report links monkeypox to neurologic issues in 2 patients; causality and frequency unknown.

A case report describes two patients in Colorado and the District of Columbia, United States, who developed neurologic complications associated with monkeypox infection. The report documents 2 cases of these complications. No comparator group, specific neurologic outcomes, effect sizes, or statistical measures were reported.

Safety and tolerability data, including adverse events, serious adverse events, and discontinuations, were not reported for these patients. The follow-up duration was also not specified.

Key limitations include the inherent nature of a case report, which cannot establish causality, frequency, or risk. The sample size is only 2 patients, and no data on the broader population or clinical course is provided. Funding sources and author conflicts of interest were not reported.

For practice, this report suggests clinicians should be aware that neurologic complications can occur in patients with monkeypox. However, this evidence is extremely preliminary and cannot inform estimates of incidence, risk factors, or prognosis. The clinical relevance and appropriate management of such complications remain undefined.

A new medical report describes two patients in the United States who developed neurological complications while infected with monkeypox. The cases occurred in Colorado and Washington, D.C. The report does not provide details about the specific neurological symptoms, the patients' overall health, or their recovery.

This is a case report, which is the most basic form of medical evidence. It simply documents what doctors observed in these two individuals. The report does not include any data on how frequently this happens, how severe it is, or whether the monkeypox virus directly caused the neurological problems.

Because this is only about two people, it cannot tell us anything about risk for the general population. It serves as an early alert for doctors to watch for these symptoms. For the public, it is a reminder that any new virus can have unexpected effects, but this finding is too limited to change how we understand or manage monkeypox.

What this means for you:
A report notes neurological issues in two monkeypox patients, but this is very rare and not proof of cause.

Study Details

EvidenceLevel 5
PublishedSep 2022
View Original Abstract ↓
This report describes two cases of monkeypox-associated neurologic complications in the United States.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.